ECSP15032911A - PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND CONTRACEPTIVE KIT (DIVISIONAL 1 APPLICATION No. SP-12-12359 PCT) - Google Patents

PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND CONTRACEPTIVE KIT (DIVISIONAL 1 APPLICATION No. SP-12-12359 PCT)

Info

Publication number
ECSP15032911A
ECSP15032911A ECIEPI201532911A ECPI201532911A ECSP15032911A EC SP15032911 A ECSP15032911 A EC SP15032911A EC IEPI201532911 A ECIEPI201532911 A EC IEPI201532911A EC PI201532911 A ECPI201532911 A EC PI201532911A EC SP15032911 A ECSP15032911 A EC SP15032911A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical composition
divisional
pct
application
drospirenone
Prior art date
Application number
ECIEPI201532911A
Other languages
Spanish (es)
Inventor
Drouin Dominique
Velada Jose
Perrin Philippe
Original Assignee
Perrin Philippe
Laboratorios Leon Farma S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48802149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP15032911(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2011/060795 external-priority patent/WO2012000981A1/en
Application filed by Perrin Philippe, Laboratorios Leon Farma S A filed Critical Perrin Philippe
Publication of ECSP15032911A publication Critical patent/ECSP15032911A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere al campo de las composiciones farmacéuticas y métodos anticonceptivos. La presente invención proporciona una composición farmacéutica que comprende drospirenona caracterizada por una velocidad de disolución lenta de la drospirenona in vitro y un perfil farmacocinético mejorado. Está asimismo prevista la utilización de dicha composición en los métodos anticonceptivos y en los kits.The present invention relates to the field of pharmaceutical compositions and contraceptive methods. The present invention provides a pharmaceutical composition comprising drospirenone characterized by a slow dissolution rate of drospirenone in vitro and an improved pharmacokinetic profile. The use of said composition in contraceptive methods and kits is also planned.

ECIEPI201532911A 2010-06-29 2015-07-28 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND CONTRACEPTIVE KIT (DIVISIONAL 1 APPLICATION No. SP-12-12359 PCT) ECSP15032911A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10305708 2010-06-29
US36839610P 2010-07-28 2010-07-28
PCT/EP2011/060795 WO2012000981A1 (en) 2010-06-29 2011-06-28 Pharmaceutical composition comprising drospirenone and contraceptive kit

Publications (1)

Publication Number Publication Date
ECSP15032911A true ECSP15032911A (en) 2016-01-29

Family

ID=48802149

Family Applications (3)

Application Number Title Priority Date Filing Date
ECSP12012359 ECSP12012359A (en) 2010-06-29 2012-10-27 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT
ECIEPI201532906A ECSP15032906A (en) 2010-06-29 2015-07-28 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND CONTRACEPTIVE KIT (DIVISIONAL 2 APPLICATION No. SP-12-12359 PCT)
ECIEPI201532911A ECSP15032911A (en) 2010-06-29 2015-07-28 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND CONTRACEPTIVE KIT (DIVISIONAL 1 APPLICATION No. SP-12-12359 PCT)

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ECSP12012359 ECSP12012359A (en) 2010-06-29 2012-10-27 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-CONCEPTIVE KIT
ECIEPI201532906A ECSP15032906A (en) 2010-06-29 2015-07-28 PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND CONTRACEPTIVE KIT (DIVISIONAL 2 APPLICATION No. SP-12-12359 PCT)

Country Status (14)

Country Link
KR (1) KR102210982B1 (en)
BR (1) BR122019008317A2 (en)
CL (1) CL2012003685A1 (en)
CO (1) CO6640328A2 (en)
DK (1) DK2588114T3 (en)
EC (3) ECSP12012359A (en)
ES (1) ES2777886T3 (en)
GT (3) GT201200336BA (en)
HR (1) HRP20200155T1 (en)
HU (1) HUE047689T2 (en)
LT (2) LT2588114T (en)
MX (3) MX364971B (en)
PT (1) PT2588114T (en)
ZA (1) ZA201209743B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone

Also Published As

Publication number Publication date
ZA201209743B (en) 2014-03-26
ES2777886T3 (en) 2020-08-06
CO6640328A2 (en) 2013-03-22
CL2012003685A1 (en) 2013-07-05
BR122019008317A2 (en) 2020-09-29
ECSP15032906A (en) 2016-01-29
LT2588114T (en) 2020-02-25
MX364971B (en) 2019-05-16
GT201200336A (en) 2014-01-14
GT201200336AA (en) 2017-10-23
HUE047689T2 (en) 2020-05-28
HRP20200155T1 (en) 2020-05-01
KR102210982B1 (en) 2021-02-02
MX2019004393A (en) 2019-09-09
DK2588114T3 (en) 2020-02-17
KR20190073598A (en) 2019-06-26
LTPA2021523I1 (en) 2021-11-10
PT2588114T (en) 2020-02-20
MX2012014629A (en) 2013-05-06
MX339952B (en) 2016-06-20
ECSP12012359A (en) 2013-03-28
GT201200336BA (en) 2017-10-23

Similar Documents

Publication Publication Date Title
AR081670A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-ECONCEPTIVE KIT
GT201000023A (en) NEW DERIVATIVES OF 6-TRIALZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS.
CO6410279A2 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES DERIVATIVES OF GLUCOPIRANOSIL DIFENYLMETHANE, PHARMACEUTICAL FORM OF THE SAME, PROCEDURE FOR THEIR PREPARATION AND USES OF THE SAME FOR IMPROVED GLUCEMIC CONTROL IN A PATIENT.
UA111770C2 (en) BROMDOMEN INHIBITORS
CL2017003218A1 (en) Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
MD20130095A2 (en) Fused benzoxazepinones as ion channel modulators
NI201200184A (en) MORPHOLINOPYRIMIDINES AND THEIR USE IN THERAPY
CR20110216A (en) 1-AMINO-2-CYCLLOBUTILETILBORONIC ACID DERIVATIVES
EA201291310A1 (en) JAK INHIBITOR COMPOSITION FOR LOCAL APPLICATION
CO6741203A2 (en) Bicyclo derivatives [3,2,1] octylamide and their uses
CR20110318A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS TO BE USED IN THE TREATMENT OF METABOLIC DISORDERS
HN2008001521A (en) DIMEROS OF ARTEMISININE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
MA34055B1 (en) AGOMELATIN HYDRATE HYDROCHLORIDE AND ITS PREPARATION
MX2013001234A (en) Deuterated tandospirone derivatives as 5-ht1a receptor agonists.
HN2011002578A (en) NEW DERIVATIVES OF COMPOUNDS OF [3,2-C] STEROID PIRAZOL WITH CLUCOCORTICOID ACTIVITY.
BR112014020271A8 (en) PHARMACEUTICAL COMPOSITION AND METHODS TO DECREASE URINATION FREQUENCY IN PATIENTS
CY1122596T1 (en) NEW PHARMACEUTICAL FORMS OF (TRIMETHOXYPHENYLAMINO)PYRIMIDINYL
AR063027A1 (en) SULFONAMIDE DERIVATIVES
ECSP10010578A (en) PHARMACEUTICAL COMPOSITION 271
UY32247A (en) NEW AMINOCICLOHEXILO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF THE SAME AND APPLICATIONS
ECSP15032911A (en) PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND CONTRACEPTIVE KIT (DIVISIONAL 1 APPLICATION No. SP-12-12359 PCT)
ECSP099328A (en) PIRAZOL ANALOGS
DOP2015000127A (en) PHARMACEUTICAL FORMULATION OF N- [5- [2- (3,5-DIMETOXIFENIL) ETIL] -2H-PIRAZOL-3-IL] -4 - [(3R, 5S) -3,5-DIMETHYLIPIPERAZIN-1-IL] BENZAMIDA
ECSP10010292A (en) NEW DERIVATIVES OF 2-MERCAPTOCICLOPENTANOCARBOXÍLICO ACID, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CR20120109A (en) NEW DIHIDRO-OXAZOLOBENZODIAZEPINONAS DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM